✦ LIBER ✦

Efficacy of Single-Dose Dexamethasone as Adjuvant Therapy for Acute Pharyngitis

✍ Scribed by Julie L. Wei; Jan L. Kasperbauer; Amy L. Weaver; Andrew J. Boggust

Book ID: 110083898
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 135 KB
Volume: 112
Category: Article
ISSN: 0023-852X
DOI: 10.1097/00005537-200201000-00016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dexamethasone as adjuvant therapy for se

Dexamethasone as adjuvant therapy for severe acute pharyngitis

✍ John F O'Brien; John L Meade; Jay L Falk 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 304 KB

Setting: Large, urban community hospital emergency department with an emergency medicine residency program. Type of participants: Patients aged 12 to 65 years 01d with exudative pharyngitis and severe dysphagia/odynophagia. Patients with cancer, AIDS, diabetes mellitus, recent steroid use, pregnanc

Efficacy of intravenous immune globulin

Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease

✍ Toshiaki Jibiki; Masaru Terai; Tomomichi Kurosaki; Hiromichi Nakajima; Kazuhiro 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 176 KB

Efficacy of mycophenolate mofetil as sin

Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura

✍ Drew Provan; Ashley J. Moss; Adrian C. Newland; James B. Bussel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

Limited efficacy of injectable aminosidi

Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis

✍ J. Soto; M. Grogl; J. Berman; P. Olliaro 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 585 KB

Feasibility of dose–intensive continuous

Feasibility of dose–intensive continuous 5–fluorouracil, doxorubicin, and cyclophosphamide as adjuvant therapy for breast cancer

✍ Georgiana Ellis; Robert B. Livingston 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

A single, high dose of idarubicin combin

A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia

✍ Mark A. Weiss; Timothy B. Aliff; Martin S. Tallman; Stanley R. Frankel; Matt E. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Background: The majority of adult patients who are treated for lymphoblastic disease will either develop recurrent disease or will be refractory to their initial therapy. one option for patients with recurrent/refractory disease is to administer a reinduction regimen that employs a dose-intense